Full-Time
Posted on 6/27/2024
Quality and regulatory software solutions provider
$85k - $225k/yr
Mid
Company Historically Provides H1B Sponsorship
Remote in USA
Veeva Systems offers software solutions for quality, regulatory, and advertising claims management, focusing on consumer products and chemical companies. Their cloud-based platform provides end-to-end visibility and traceability throughout the product journey, ensuring compliance with regulations and improving efficiency. Unlike competitors, Veeva has expanded from the Life Sciences sector to also serve the Chemical and Consumer Goods markets, maintaining a subscription-based model for steady revenue. The company's goal is to modernize the product journey for clients, helping them bring safe and compliant products to market faster.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Pleasanton, California
Founded
2007
Help us improve and share your feedback! Did you find this helpful?
Parental leave
PTO
Free food
Health, dental, & vision insurance
Gym membership reimbursement
SAN JOSE, Calif., May 20, 2025 /PRNewswire/ -- Spotline, Inc., a Veeva-certified product, services, and AI partner, today announced that Veeva Systems is using its V-Assure platform to enable faster, pre-validated software releases for Veeva Basicsâthe pre-configured solution designed to help emerging biotechs achieve rapid deployment and built-in GxP compliance.Veeva used Spotline's V-Assure platform to accelerate the delivery of the last three releases of Veeva Basics for clinical, regulatory, and quality. V-Assure automated testing for these applications, providing emerging biotech customers with documentation to support the Basics Production Qualification.How Spotline Supports Veeva Basics' Mission for Biotech Speed and ComplianceTo help Veeva deliver Veeva Basics efficiently as a turnkey application, Spotline:Built and maintained reusable, automated test libraries using V-AssureAdapted scripts rapidly to reflect evolving release requirementsExecuted complete, automated validation cycles before each releaseProvided automated re-execution of qualification for each Veeva Basics maintenance release.This proactive, automation-first approach helped ensure that every release was audit- and inspection-ready to support accelerated development and release management of Veeva Basics."By using Spotline's V-Assure testing platform, we can deliver complete qualification documentation across our Veeva Basics applications," said Steve Harper, General Manager of Veeva Basics. "Automating testing helps us to move faster and provide testing and documentation on behalf of our customers. This saves time and effort while accelerating application delivery for emerging biotech."Automated Validation Across Veeva Basics ApplicationsWith Spotline's V-Assure one-touch automated testing within each release cycle, Veeva successfully delivered audit- and inspection-ready validation documentation for its Veeva Basics applications in clinical, regulatory, and quality. Through the validation process, Veeva automated more than 500 test case executions across its Veeva Basics applications."Supporting the Veeva Basics team through three major releases has showcased how automated validationâwhen done rightâcan deliver speed and reliability," said Sid Sahoo, CEO of Spotline, Inc. "V-Assure is helping life sciences organizations modernize their validation processes and unlock faster adoption of compliant solutions."Meet Us at the Veeva R&D and Quality SummitsSpotline will demonstrate the latest version of V-Assure, including its enhanced integrations with Veeva Validation Management , at the upcoming Veeva R&D and Quality Summits in Europe and the U.S .Attendees are encouraged to schedule a demo at www.spotline.com/v-assure to explore how V-Assure can transform their validation operations.About Spotline Inc.Spotline Inc
Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercialPLEASANTON, Calif., April 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI, a major new initiative that adds AI to the Veeva Vault Platform and Veeva applications to help life sciences companies automate tasks and improve employee productivity using AI Agents and AI Shortcuts. Veeva AI provides a fast and efficient way to introduce application-specific AI Agents based on large language models (LLMs) into existing Veeva applications and enable end users with AI Shortcuts. Veeva AI will work in all Veeva applications across all major areas, including clinical, regulatory, safety, quality, medical, and commercial.Veeva AI Agents can be deployed quickly with high impact because they understand the Veeva application context, have application-specific prompts and safeguards, and have direct, secure access to Veeva application data, documents, and workflows. Customers can configure and extend Veeva-delivered AI Agents and build custom AI Agents to address company-specific use cases. AI Agents can be used through a chatbot user interface or called via the AI API.Veeva AI Shortcuts empower end users with the ability to easily set up personal AI-powered automations to accomplish frequent user-specific tasks such as helping with workflows, generating insights, or researching a topic."GenAI is a new computing paradigm that will significantly increase productivity for knowledge workers," said Veeva CEO Peter Gassner. "Core applications give you structured data, business rules and workflow
Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry.
Platform built in collaboration with Amazon Web Services, Modus Create to produce unmatched accuracy, efficiencies and compliance for life science companiesCHICAGO â 10 April, 2025 - EVERSANA, a leading provider of commercial services to the life sciences industry, today announced the next milestone in its journey to transform and innovate commercialization with the launch of EVERSANA ORCHESTRATE MLR, an AI-powered, industry-integrated platform that revolutionizes the Medical, Legal, and Regulatory (MLR) process.EVERSANA ORCHESTRATE MLR automates 90 percent of common tasks in the complex review process through a single platform thatâs easy to implement and complies with all regulatory requirements.The solution was built on Amazon Bedrock, which offers a choice of high-performing foundation models. EVERSANA worked with consulting firm Modus Create , EVERSANAâs Medical Affairs and Regulatory Affairs experts, and Veeva for seamless integration with Veeva PromoMats.âEVERSANA ORCHESTRATE MLR is a game-changer for the life science industry,â said Jim Lang, CEO. âThrough the power of AI and our collaborations with leading technology providers and in-house MLR experts, weâve set a new standard for efficiency, compliance, and quality that is much needed in todayâs industry.âShifting the Industry MLR Process from Manual to AutomatedMost organizations have a manual MLR review process, requiring teams to comb through hundreds of marketing materials and cross-reference them with the most accurate regulatory claims information available. EVERSANA ORCHESTRATE MLR automatically identifies, extracts and manages claims in minutes with the power of AI.Additionally, annotation and cross-referencing for creative-type documents against claims data can now be completed in just a few clicks. Users will see all claims identified in the document and what needs to be updated and can make these updates in real-time, resulting in 90 percent faster content updates and an overall reduction in content reviews by as much as 50 percent.By harnessing the power of Amazon Bedrock, EVERSANA will empower life sciences companies with the AI tools they need to mitigate a significant pain point for the healthcare industryâ administrative burden. EVERSANA ORCHESTRATE MLR is just one example of how EVERSANA is using industry-leading AI solutions to solve some of healthcareâs most complex problems.âGenerative AI is transforming the life sciences industry by accelerating R&D, improving efficiency in manufacturing, and streamlining the path to commercialization," said Dan Sheeran, general manager, Healthcare and Life Sciences, AWS
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsorsPLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system. Integration with sponsors using Veeva's Clinical Platform gives sites seamless bidirectional data flow to sponsors to reduce manual processes and increase efficiency."We need to work efficiently to help more families enroll their children in studies and get lifesaving treatment," said Theresa Oswald, director of research operations and conduct at Ann & Robert H. Lurie Children's Hospital of Chicago. "In our experience, we have found that systems like Veeva SiteVault with a CTMS provide a streamlined user experience. This can help drive speed for the benefit of our patients.""We are excited to bring Veeva SiteVault CTMS to the industry," said Nick Frenzer, general manager, site solutions at Veeva. "High-quality cloud software and seamless sponsor integration will help sites be more efficient